Cargando…

Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces

The transmission of coronavirus disease 2019 (COVID-19) in workplaces has been a persistent issue throughout the pandemic. In response, a not-for-profit initiative emerged to mitigate COVID-19 workplace transmission in Canada. We report the process for establishing a workplace frequent rapid antigen...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosella, Laura C., Agrawal, Ajay, Gans, Joshua, Goldfarb, Avi, Sennik, Sonia, Stein, Janice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880770/
https://www.ncbi.nlm.nih.gov/pubmed/35213224
http://dx.doi.org/10.1126/sciadv.abm3608
_version_ 1784659303274119168
author Rosella, Laura C.
Agrawal, Ajay
Gans, Joshua
Goldfarb, Avi
Sennik, Sonia
Stein, Janice
author_facet Rosella, Laura C.
Agrawal, Ajay
Gans, Joshua
Goldfarb, Avi
Sennik, Sonia
Stein, Janice
author_sort Rosella, Laura C.
collection PubMed
description The transmission of coronavirus disease 2019 (COVID-19) in workplaces has been a persistent issue throughout the pandemic. In response, a not-for-profit initiative emerged to mitigate COVID-19 workplace transmission in Canada. We report the process for establishing a workplace frequent rapid antigen test (RAT) program. The screening program identified 473 asymptomatic individuals who tested positive on the RAT and confirmed positive by a nasopharyngeal polymerase chain reaction (PCR) diagnostic test. One in 4300 RATs was presumptive positive but later tested PCR negative, and thus, false positives did not meaningfully disrupt workplace operations. Most employers rated the program highly and felt strongly that the program contributed to workplace and community safety. The findings describe a sustained and scalable implementation plan for establishing a frequent workplace testing program. High-frequency testing programs offer the potential to break chains of transmission and act as an extra layer of protection in a comprehensive public health response.
format Online
Article
Text
id pubmed-8880770
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-88807702022-03-10 Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces Rosella, Laura C. Agrawal, Ajay Gans, Joshua Goldfarb, Avi Sennik, Sonia Stein, Janice Sci Adv Social and Interdisciplinary Sciences The transmission of coronavirus disease 2019 (COVID-19) in workplaces has been a persistent issue throughout the pandemic. In response, a not-for-profit initiative emerged to mitigate COVID-19 workplace transmission in Canada. We report the process for establishing a workplace frequent rapid antigen test (RAT) program. The screening program identified 473 asymptomatic individuals who tested positive on the RAT and confirmed positive by a nasopharyngeal polymerase chain reaction (PCR) diagnostic test. One in 4300 RATs was presumptive positive but later tested PCR negative, and thus, false positives did not meaningfully disrupt workplace operations. Most employers rated the program highly and felt strongly that the program contributed to workplace and community safety. The findings describe a sustained and scalable implementation plan for establishing a frequent workplace testing program. High-frequency testing programs offer the potential to break chains of transmission and act as an extra layer of protection in a comprehensive public health response. American Association for the Advancement of Science 2022-02-25 /pmc/articles/PMC8880770/ /pubmed/35213224 http://dx.doi.org/10.1126/sciadv.abm3608 Text en Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Social and Interdisciplinary Sciences
Rosella, Laura C.
Agrawal, Ajay
Gans, Joshua
Goldfarb, Avi
Sennik, Sonia
Stein, Janice
Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces
title Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces
title_full Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces
title_fullStr Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces
title_full_unstemmed Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces
title_short Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces
title_sort large-scale implementation of rapid antigen testing system for covid-19 in workplaces
topic Social and Interdisciplinary Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880770/
https://www.ncbi.nlm.nih.gov/pubmed/35213224
http://dx.doi.org/10.1126/sciadv.abm3608
work_keys_str_mv AT rosellalaurac largescaleimplementationofrapidantigentestingsystemforcovid19inworkplaces
AT agrawalajay largescaleimplementationofrapidantigentestingsystemforcovid19inworkplaces
AT gansjoshua largescaleimplementationofrapidantigentestingsystemforcovid19inworkplaces
AT goldfarbavi largescaleimplementationofrapidantigentestingsystemforcovid19inworkplaces
AT senniksonia largescaleimplementationofrapidantigentestingsystemforcovid19inworkplaces
AT steinjanice largescaleimplementationofrapidantigentestingsystemforcovid19inworkplaces